Kilter Group’s Inspire Medical Systems INSP Stock Holding History

Kilter Group’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$75	–	1448
2025 Q3	$75	Hold	1	–	–	﹤0.01%	1202
2025 Q2	$130	Buy	+1	New	+$145	﹤0.01%	1133

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Kilter Group's INSP Position: Q4 2025 in Review

Kilter Group sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 1 share — an estimated $75 sold.

Kilter Group first reported a position in INSP in Q2 2025 and held it in 2 quarters. The position peaked at $130 in Q2 2025. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

Kilter Group reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
Kilter Group sold 1 Inspire Medical Systems share in Q4 2025, an estimated $75.
Kilter Group first reported a position in Inspire Medical Systems in Q2 2025 and held it in 2 quarters.
Kilter Group's Inspire Medical Systems position peaked at $130 in Q2 2025.
342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Kilter Group's 13F filing for Q4 2025, filed 13 Feb 2026.